Lactocore Overview

  • Status
  • Private
  • Latest Deal Type
  • Accelerator/​Inc
  • Investors
  • 1

Lactocore General Information


Developer of novel peptide-based therapies intended to address unmet medical needs of psychiatric conditions within the spectrum of depressive and anxiety disorders. The company's therapy helps to identify an unknown family of peptides with biological activity in anxiety and depression, by means of proprietary processing of whey and casein from bovine's milk, enabling baby food manufacturers to reduces the risk of the motor mental retardation through their food product.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Other Industries
Media and Information Services (B2B)
Primary Office
  • 46701 Commerce Center Drive
  • Plymouth, MI 48170
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Lactocore Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Accelerator/Incubator 01-Apr-2012 Completed Pre-Clinical Trials
To view Lactocore’s complete valuation and funding history, request access »

Lactocore Executive Team (4)

Name Title Board Seat Contact Info
Askar Kuchumov Ph.D Chief Executive Officer
Igor Doronin Co-Founder & Director of PD
Anton Malyshev Co-Founder & CSO
Gennady Babkin Co-Founder
To view Lactocore’s complete executive team members history, request access »

Lactocore Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
MSU Business Incubator Accelerator/Incubator Minority 000 0000 000000 0
To view Lactocore’s complete investors history, request access »